Aptadel, the new IDIBELL’s spinoff

by Hospital Universitari de Bellvitge

Aptadel Therapeutics is a preclinical company co-founded by IDIBELL focused on developing a new platform for targeted therapy against cancer. This platform consists of nanoparticles loaded with therap...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

El Plan Integral de eliminación de Hepa...

by Hospital Universitario Virgen de la Macarena

​Esta estrategia ha proporcionado facilidades de derivación desde a...

Photos Stream